Production (Stage)
Eupraxia Pharmaceuticals Inc.
EPRX.TO
TSX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -23.54% | 71.14% | -64.72% | 61.69% | 157.76% |
| Total Receivables | 42.64% | 20.09% | 55.28% | 200.19% | 91.74% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 548.19% | 308.76% | 222.41% | 144.64% | -23.88% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -21.01% | 73.90% | -60.39% | 64.56% | 154.99% |
|
|
|||||
| Total Current Assets | -21.01% | 73.90% | -60.39% | 64.56% | 154.99% |
| Net Property, Plant & Equipment | 31.72% | -6.86% | 7.61% | -3.45% | -14.63% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1,332.14% | 1,071.01% | 493.55% | 4.55% | 166.67% |
| Total Assets | -20.21% | 72.42% | -59.18% | 62.51% | 149.38% |
|
|
|||||
| Total Accounts Payable | -- | -- | -- | -- | -- |
| Total Accrued Expenses | -46.12% | -22.14% | -12.97% | -20.12% | 209.22% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -99.45% | -99.31% | -99.31% | -44.70% | 7,107.92% |
| Total Finance Division Other Current Liabilities | -99.11% | -99.59% | -91.21% | 2,136.91% | 2,246.41% |
| Total Other Current Liabilities | -99.11% | -99.59% | -91.21% | 2,136.91% | 2,246.41% |
| Total Current Liabilities | -88.13% | -83.98% | -83.35% | 5.23% | 1,050.61% |
|
|
|||||
| Total Current Liabilities | -88.13% | -83.98% | -83.35% | 5.23% | 1,050.61% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | 64.37% | 49.57% | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -88.13% | -83.98% | -83.26% | 5.12% | 95.58% |
|
|
|||||
| Common Stock & APIC | 3.71% | 23.94% | 31.47% | 52.26% | 63.07% |
| Retained Earnings | -23.51% | -24.17% | -36.15% | -41.21% | -47.37% |
| Treasury Stock & Other | -50.51% | -53.72% | -- | -- | -- |
| Total Common Equity | -115.87% | -23.31% | -24.44% | 164.01% | 206.32% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -115.87% | -23.31% | -24.44% | 164.01% | 206.32% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -9.23% | -18.27% | -5.28% | -13.25% | -23.59% |
| Total Equity | 49.30% | 3,468.19% | -28.35% | 210.30% | 247.06% |
|
|
|||||